glp 1 lawsuit Lipsitz, Ponterio & Comerford On February 2, 2026, Pope
Description
Lim DM, Park KY, Hwang WM, Kim JY, Kim BJ
The claims are not supportable by this kind of study, he said
As evidence grows, these guidelines must evolve to reflect the latest research, ensuring patients receive the most effective care
WHO in September added GLP-1 drugs as a diabetes treatment to its list of essential medicines, but stopped short of adding them for obesity alone
